Lundbeck

Overview

Lundbeck is a global biopharmaceutical company based in Copenhagen, Denmark, specializing in the research, development, manufacturing, and commercialization of innovative treatments for brain diseases and central nervous system (CNS) disorders. Founded in 1915, the organization has evolved from a general trading house into a leader in neuroscience-focused pharmaceuticals.

The company has launched more than 30 treatments, with a strong emphasis on psychiatric and neurological disorders. Operating in over 50 countries, its products reach more than 7 million people daily. The Lundbeck Foundation, established in 1954, holds a majority share and underpins its ongoing commitment to scientific research and pharmaceutical development.

Basic Information

Contact Details

• Phone: +45 36 30 13 11
• Website: lundbeck.com
• LinkedIn: linkedin.com/company/lundbeck

Key Focus Areas & Initiatives

• neuroscience research
• schizophrenia
• psychosis
• parkinsons disease
• alzheimers disease
• depression
• mental health
• psychiatry
• neurology
• brain health
• migraine
• brain disease
• neurorare
• neurospeciality
• pharmaceutical manufacturing
• brain disease pipeline
• responsible business
• global markets
• brain health solutions
• brain disorders
• brain research
• sustainability
• brain disease treatments
• biopharmaceuticals
• patient-centric
• neurotherapeutics
• brain disease research
• patient care
• brain health development
• brain diseases
• research centers
• collaborations
• brain health research
• product development
• brain health advocacy
• brain disease management
• b2b
• medical innovation
• manufacturing facilities
• biotechnology
• brain health products
• brain disease therapies
• pharmaceuticals
• neuroscience
• brain health therapies
• product pipeline
• healthcare
• neurological treatments
• brain health innovation
• services
• clinical research
• r&d investment
• pharmaceutical and medicine manufacturing
• brain health treatments
• pharmaceutical development
• clinical trials
• brain disease innovation
• brain disease development
• brain disease solutions
• psychiatric disorders
• anxiety
• bipolar disorder
• alzheimer's disease
• parkinson's disease
• research and development
• medical treatments
• cognitive symptoms
• emotional symptoms
• physical symptoms
• mental health advocacy
• neuropharmacology
• drug development
• therapeutic options
• medical education
• clinical data sharing
• corporate governance
• diversity and inclusion
• global health
• clinical safety
• innovation in healthcare
• partnership initiatives
• mental health stigma
• patient engagement
• mental illness
• disease management
• harm reduction
• mental wellness programs
• neurodegenerative diseases
• mental health resources
• community engagement
• biomedical research
• psychotropic medications
• clinical efficacy
• healthcare reforms
• international collaborations
• mental illness treatments
• medical compliance
• ethical drug development
• mental health research funding
• manufacturing
• hospital & health care
• medical
• environmental services
• renewables & environment
• health care
• health, wellness & fitness
• research & development
• mechanical or industrial engineering

Technologies Used

• ANGEL LMS
• AWS Trusted Advisor
• Adobe Marketing Cloud
• Adobe Media Optimizer
• Amazon AWS
• Amazon CloudFront
• Apache
• Atlassian Cloud
• Benchling
• Cedexis Radar
• Cision
• Citrix NetScaler
• Drupal
• Facebook
• Google AdWords Conversion
• Google Analytics
• ICP
• ISO+™
• LabWare LIMS
• Linkedin Marketing Solutions
• Microsoft Azure Monitor
• Microsoft Excel
• Microsoft Office
• Microsoft PowerPoint
• Mobile Friendly
• Mode
• Olo
• Outlook
• Route 53
• SAP
• SAP Business Planning and Consolidation (BPC)
• SAP SuccessFactors
• Salesforce
• Salesforce CRM Analytics
• ServiceNow
• Slack
• Vimeo
• WordPress.org
• YouTube

Affiliated Organizations & Regional Branches

• Abide Therapeutics, Inc.
• Prexton Therapeutics SA
• Chelsea Therapeutics International
• Alder Biopharmaceuticals
• Longboard Pharmaceuticals